Skip to main content
Premium Trial:

Request an Annual Quote

Public Project to Publish Human Genome in Science by Year s End

NEW YORK, Sept 7 – An international group of 30 public scientists are currently annotating the human genome with the hope of publishing the data in December, Eric Lander, director of MIT’s Whitehead Institute for Genome Research, said Thursday.

“My feeling is that Science will devote an entire special issue to it at the turn of the year,” Lander told people at the opening of the “Paradise Now: Picturing the Genetic Revolution” exhibit in a gallery in New York’s Soho art district.

They have yet, however, to submit a paper to the journal, he said.

Celera (NYSE:CRA) has said that they are also planning to publish their annotation data by the end of the year. Industry experts have speculated that the papers submitted by the private and public projects would be published together.

With a brightly colored painting of square cucumbers and oversized genetically modified cows, chickens, and crops as backdrop, Lander told the crowd that genome annotation is a lot like genome art.

Both disciplines seek to draw meaning from the human genome, he said.

While researchers seek to add scientific meaning to the raw sequence data of the human genome – the string of 3.1 billion A’s, C’s, G’s, and T’s – art wrestles with finding the meaning of the data in a social context.

“That’s not a question you could answer with science,” said Lander. “For that you have to look to art, to literature, to philosophy,” Lander said.

In turn, both artists and scientists can look to the genome for new understanding about what people see when they look at art.

“The number of red and green color receptors on the X chromosome varies – some people have three or four, some people have one or two. And nobody really has digested what this means for how you perceive art,” he said.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.